Participants 81 124 6
autism and pervasive developmental disorder
Participants 529 609 7
60 children (age, 3 to 14 years) with autism or pervasive developmental disorder
Participants 1030 1143 3
60 children, 4 could not be evaluated - 2 received secretin outside the study, and 2 did not return for follow-up
Participants 1151 1201 4
56 children (28 in each group) completed the study
Participants 1799 1807 3
children
